VIPpharma ApS — Credit Rating and Financial Key Figures
CVR number: 38744763
Bjælkevangen 9, 2690 Karlslunde
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 150.97 | 2 076.34 | 2 357.49 | 2 585.00 | 3 138.70 |
| Wages and salaries | -1 041.53 | -1 268.05 | -1 279.49 | -1 321.72 | -1 384.66 |
| Social security expenses | -99.22 | -97.13 | -97.57 | - 136.09 | - 121.97 |
| Other operating expenses | -8.95 | ||||
| Total depreciation | - 117.81 | - 165.15 | - 165.15 | - 165.15 | -79.62 |
| EBIT | 892.41 | 537.06 | 815.27 | 962.04 | 1 552.44 |
| Other financial income | 2.91 | 19.25 | 17.13 | 16.93 | 17.08 |
| Other financial expenses | -9.45 | -6.00 | -4.23 | -0.23 | -0.23 |
| Pre-tax profit | 884.44 | 557.91 | 824.57 | 978.11 | 1 564.26 |
| Income taxes | - 168.76 | - 129.42 | - 191.07 | - 234.65 | - 372.78 |
| Net earnings | 715.68 | 428.49 | 633.50 | 743.46 | 1 191.48 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Goodwill | 896.00 | 840.00 | 784.00 | 728.00 | 672.00 |
| Intangible assets total | 896.00 | 840.00 | 784.00 | 728.00 | 672.00 |
| Machinery and equipment | 351.07 | 241.92 | 132.77 | 23.62 | |
| Tangible assets total | 351.07 | 241.92 | 132.77 | 23.62 | |
| Investments total | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 346.63 | 384.38 | 546.63 | 563.50 | 621.32 |
| Current amounts owed by group member comp. | 115.83 | 210.37 | |||
| Current owed by particip. interest comp. | 750.00 | 108.37 | |||
| Current other receivables | 269.93 | 822.18 | 838.28 | 852.05 | 872.00 |
| Current deferred tax assets | 92.25 | 166.22 | |||
| Short term receivables total | 1 458.81 | 1 481.14 | 1 500.73 | 1 415.55 | 1 703.69 |
| Other current investments | 4.66 | 6.74 | 9.04 | 9.68 | 10.20 |
| Cash and bank deposits | 1 685.54 | 507.68 | 456.43 | 721.81 | 364.28 |
| Cash and cash equivalents | 1 690.20 | 514.42 | 465.47 | 731.49 | 374.48 |
| Balance sheet total (assets) | 4 426.08 | 3 107.48 | 2 912.98 | 2 928.66 | 2 780.17 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 1 750.00 | 1 000.00 | 1 000.00 | 1 100.00 | 1 250.00 |
| Retained earnings | 1 175.93 | 891.61 | 320.09 | - 146.40 | - 652.94 |
| Profit of the financial year | 715.68 | 428.49 | 633.50 | 743.46 | 1 191.48 |
| Shareholders equity total | 3 691.61 | 2 370.09 | 2 003.60 | 1 747.06 | 1 838.54 |
| Provisions | 229.56 | 204.43 | 176.49 | 146.46 | 133.67 |
| Non-current other liabilities | 15.00 | 15.00 | |||
| Non-current deferred tax liabilities | 219.00 | 15.00 | 15.00 | ||
| Non-current liabilities total | 15.00 | 234.00 | 15.00 | 15.00 | |
| Current owed to group member | 94.49 | 219.44 | |||
| Short-term deferred tax liabilities | 264.65 | 385.57 | |||
| Other non-interest bearing current liabilities | 504.91 | 423.47 | 498.89 | 212.44 | 59.89 |
| Current liabilities total | 504.91 | 517.96 | 498.89 | 696.52 | 445.46 |
| Balance sheet total (liabilities) | 4 426.08 | 3 107.48 | 2 912.98 | 2 605.04 | 2 432.67 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.